Table of Content


1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
TABLE 1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 43
1.3.1 MARKETS COVERED 43
1.3.2 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44

2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
2.2 RESEARCH DESIGN 45
2.2.1 SECONDARY DATA 46
2.2.1.1 Secondary sources 46
2.2.2 PRIMARY DATA 47
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.3 MARKET SIZE ESTIMATION 48
2.3.1 BOTTOM-UP APPROACH 48
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 49
2.3.2 TOP-DOWN APPROACH 49
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 49
2.3.3 GROWTH FORECAST 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 50
FIGURE 4 DATA TRIANGULATION METHODOLOGY 50
2.5 ASSUMPTIONS FOR THE STUDY 51

3 EXECUTIVE SUMMARY 52
FIGURE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025
(USD MILLION) 52
FIGURE 6 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020 VS. 2025
(USD MILLION) 53
FIGURE 7 BLOOD SCREENING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 53
FIGURE 8 BLOOD SCREENING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 54
_

4 PREMIUM INSIGHTS 55
4.1 BLOOD SCREENING MARKET OVERVIEW 55
FIGURE 9 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 55
4.2 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION) 55
FIGURE 10 REAGENTS & KITS SEGMENT DOMINATES THE BLOOD SCREENING MARKET 55
4.3 BLOOD SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 11 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 56

5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 57
5.2.1.1 Increasing demand for donated blood and rising number of blood donations 57
TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 58
5.2.1.2 Rising prevalence of infectious diseases and the emergence of newer pathogens 58
5.2.2 OPPORTUNITIES 59
5.2.2.1 Technological advancements 59
5.2.2.2 Emerging economies 59
5.2.3 CHALLENGES 60
5.2.3.1 Need for reducing blood screening prices 60
5.3 COVID-19 IMPACT ON THE BLOOD SCREENING MARKET 60
5.4 ADJACENT MARKETS 61
TABLE 3 ADJACENT MARKETS FOR BLOOD SCREENING MARKET (USD MILLION) 61

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE 62
6.1 INTRODUCTION 63
TABLE 4 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019
(USD MILLION) 63
TABLE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025
(USD MILLION) 63
6.2 REAGENTS & KITS 64
TABLE 6 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION) 64
TABLE 7 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 64
TABLE 8 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 65
TABLE 9 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 65
6.2.1 NAT REAGENTS & KITS 65
6.2.1.1 High sensitivity and rising use of NAT are boosting demand for related reagents and kits 65
TABLE 10 NAT REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION) 66
TABLE 11 NAT REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 66
TABLE 12 NAT REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 66
TABLE 13 NAT REAGENTS & KITS MARKET, BY TYPE, 2021–2025 (USD MILLION) 67
6.2.1.2 Enzymes & polymerases 67
6.2.1.3 Standards & controls 67
6.2.1.4 Probes & primers 67
6.2.1.5 Buffers, nucleotides, and solutions 67
6.2.1.6 Labeling & detection reagents 67
6.2.2 ELISA REAGENTS & KITS 68
6.2.2.1 Ease of use and cost-effectiveness of ELISA reagents & kits will drive market growth 68
TABLE 14 ELISA REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION) 68
TABLE 15 ELISA REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 68
TABLE 16 ELISA REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 69
TABLE 17 ELISA REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 69
6.2.2.2 Immunosorbents 69
6.2.2.3 Controls 69
6.2.2.4 Conjugates 69
6.2.2.5 Substrates 70
6.2.2.6 Sample diluents & wash solutions 70
6.2.3 OTHER REAGENTS & KITS 70
6.2.3.1 Increasing use of western blot tests and rapid tests will drive the growth of this market segment 70
TABLE 18 OTHER REAGENTS & KITS MARKET, BY REGION, 2018–2020 (USD MILLION) 70
TABLE 19 OTHER REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 71
6.3 INSTRUMENTS 71
TABLE 20 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2016–2019
(USD MILLION) 71
TABLE 21 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2020–2025
(USD MILLION) 72
TABLE 22 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2016–2019 (USD MILLION) 72
TABLE 23 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2020–2025 (USD MILLION) 72
6.3.1 RENTAL PURCHASE 73
6.3.1.1 Convenience and cost-effectiveness of renting instruments has resulted in a greater end-user preference 73
TABLE 24 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS,
BY REGION, 2016–2019 (USD MILLION) 73
TABLE 25 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS,
BY REGION, 2020–2025 (USD MILLION) 73
6.3.2 OUTRIGHT PURCHASE 74
6.3.2.1 Availability of government support will increase the outright purchase of instruments 74
TABLE 26 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2016–2019 (USD MILLION) 74
TABLE 27 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2020–2025 (USD MILLION) 74
6.4 SOFTWARE & SERVICES 75
6.4.1 INCREASING ADOPTION OF INSTRUMENTS WILL DRIVE THE DEMAND FOR RELATED SOFTWARE AND SERVICES 75
TABLE 28 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 75
TABLE 29 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 75

7 BLOOD SCREENING MARKET, BY TECHNOLOGY 76
7.1 INTRODUCTION 77
TABLE 30 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 77
TABLE 31 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 77
7.2 NUCLEIC ACID TESTING 77
TABLE 32 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2016–2019
(USD MILLION) 78
TABLE 33 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2020–2025
(USD MILLION) 78
TABLE 34 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 79
TABLE 35 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 79
7.2.1 TRANSCRIPTION-MEDIATED AMPLIFICATION 79
7.2.1.1 High sensitivity of these assays to support market growth 79
TABLE 36 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2016–2019 (USD MILLION) 80
TABLE 37 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2020–2025 (USD MILLION) 80
7.2.2 REAL-TIME POLYMERASE CHAIN REACTION 80
7.2.2.1 Real-time PCR procedures provide more accurate and effective results as compared to conventional PCR 80
TABLE 38 REAL-TIME PCR MARKET, BY REGION, 2016–2019 (USD MILLION) 81
TABLE 39 REAL-TIME PCR MARKET, BY REGION, 2020–2025 (USD MILLION) 81
7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY 81
TABLE 40 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2016–2019
(USD MILLION) 82
TABLE 41 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2020?2025
(USD MILLION) 82
TABLE 42 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016?2019
(USD MILLION) 83
TABLE 43 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025
(USD MILLION) 83
7.3.1 CHEMILUMINESCENCE IMMUNOASSAY 83
7.3.1.1 CLIA is ultrasensitive, automated, and a good alternative to conventional methodologies 83
TABLE 44 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016–2019 (USD MILLION) 84
TABLE 45 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2020–2025 (USD MILLION) 84
7.3.2 FLUORESCENT IMMUNOASSAY 84
7.3.2.1 Rising demand for safer and stable reagents and the development of novel markers to support the growth of this market segment 84
TABLE 46 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2016–2019
(USD MILLION) 85
TABLE 47 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2020–2025
(USD MILLION) 85
7.3.3 COLORIMETRIC IMMUNOASSAYS 85
7.3.3.1 CI offers low sensitivity as it uses vulnerable/limited signal amplification strategies 85
TABLE 48 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2016–2019
(USD MILLION) 86
TABLE 49 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2020–2025
(USD MILLION) 86
7.4 RAPID TESTS 86
7.4.1 RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH 86
TABLE 50 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2016–2019 (USD MILLION) 87
TABLE 51 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2020–2025 (USD MILLION) 87
7.5 WESTERN BLOT ASSAYS 87
7.5.1 GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS 87
TABLE 52 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2016–2019 (USD MILLION) 88
TABLE 53 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2020–2025 (USD MILLION) 88
7.6 NEXT-GENERATION SEQUENCING 89
7.6.1 NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET 89
TABLE 54 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2016–2019
(USD MILLION) 89
TABLE 55 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2020–2025
(USD MILLION) 89

8 BLOOD SCREENING MARKET, BY END USER 90
8.1 INTRODUCTION 91
TABLE 56 BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 91
TABLE 57 BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 91
_
8.2 BLOOD BANKS 91
8.2.1 BLOOD BANKS HOLD THE LARGEST SHARE OF THE BLOOD SCREENING MARKET 91
TABLE 58 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2016–2019 (USD MILLION) 92
TABLE 59 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2020–2025 (USD MILLION) 92
8.3 HOSPITALS 92
8.3.1 INCREASING G NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT 92
TABLE 60 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2016–2019
(USD MILLION) 93
TABLE 61 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2020–2025
(USD MILLION) 93

9 BLOOD SCREENING MARKET, BY REGION 94
9.1 INTRODUCTION 95
TABLE 62 BLOOD SCREENING MARKET, BY REGION, 2016–2019 (USD MILLION) 95
TABLE 63 BLOOD SCREENING MARKET, BY REGION, 2020–2025 (USD MILLION) 95
9.2 NORTH AMERICA 96
FIGURE 12 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT 96
TABLE 64 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 97
TABLE 65 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 97
TABLE 66 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY,
2016–2019 (USD MILLION) 97
TABLE 67 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 98
TABLE 68 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE,
2016–2019 (USD MILLION) 98
TABLE 69 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE,
2020–2025 (USD MILLION) 98
TABLE 70 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 99
TABLE 71 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 99
TABLE 72 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 99
TABLE 73 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 100
TABLE 74 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 100
TABLE 75 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 100
TABLE 76 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET,
BY PURCHASE TYPE, 2016–2019 (USD MILLION) 101
TABLE 77 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 101
TABLE 78 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 101
TABLE 79 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 101
9.2.1 US 102
9.2.1.1 The US dominates the global blood screening market 102
9.2.1.2 COVID-19 Impact Analysis 102
TABLE 80 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025 102
TABLE 81 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 103
TABLE 82 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 103
TABLE 83 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 103
TABLE 84 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 104
TABLE 85 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 104
TABLE 86 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 104
TABLE 87 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 104
TABLE 88 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 105
TABLE 89 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 105
TABLE 90 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 105
TABLE 91 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 105
TABLE 92 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 106
TABLE 93 US: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 106
TABLE 94 US: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 106
9.2.2 CANADA 106
9.2.2.1 Growing volume of surgical procedures performed and the high burden of cancer to support market growth 106
9.2.2.2 COVID-19 Impact Analysis 107
TABLE 95 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 107
TABLE 96 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 107
TABLE 97 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 108
TABLE 98 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 108
TABLE 99 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 108
TABLE 100 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 108
TABLE 101 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 109
TABLE 102 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 109
TABLE 103 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 109
TABLE 104 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 110
TABLE 105 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 110
TABLE 106 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 110
TABLE 107 CANADA: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 110
TABLE 108 CANADA: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 111
9.3 EUROPE 111
TABLE 109 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019
(USD MILLION) 111
TABLE 110 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025
(USD MILLION) 112
TABLE 111 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 112
TABLE 112 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 112
TABLE 113 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 113
TABLE 114 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 113
TABLE 115 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 113
TABLE 116 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 113
TABLE 117 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 114
TABLE 118 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 114
TABLE 119 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 114
TABLE 120 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 115
TABLE 121 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 115
TABLE 122 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 115
TABLE 123 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 115
TABLE 124 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 116
9.3.1 GERMANY 116
9.3.1.1 Germany is the largest market for blood screening technologies in Europe 116
9.3.1.2 COVID-19 Impact Analysis 116
TABLE 125 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 116
TABLE 126 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 117
TABLE 127 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 117
TABLE 128 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 117
TABLE 129 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 117
TABLE 130 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 118
TABLE 131 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 118
TABLE 132 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 118
TABLE 133 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 119
TABLE 134 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 119
TABLE 135 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 119
TABLE 136 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 120
TABLE 137 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 120
TABLE 138 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 120
9.3.2 FRANCE 120
9.3.2.1 Increasing prevalence of HIV to support market growth 120
TABLE 139 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 121
TABLE 140 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 121
TABLE 141 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 121
TABLE 142 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 122
TABLE 143 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 122
TABLE 144 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 122
TABLE 145 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 123
TABLE 146 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 123
TABLE 147 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 123
TABLE 148 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 124
TABLE 149 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 124
TABLE 150 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 124
TABLE 151 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 124
TABLE 152 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 125
9.3.3 UK 125
9.3.3.1 Government support to prevent transmission of HIV and other infections will drive market growth 125
9.3.3.2 COVID-19 Impact Analysis 125
TABLE 153 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 126
TABLE 154 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 126
TABLE 155 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 126
TABLE 156 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 127
TABLE 157 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 127
TABLE 158 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 127
TABLE 159 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 127
TABLE 160 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 128
TABLE 161 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 128
TABLE 162 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 128
TABLE 163 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2016–2019 (USD MILLION) 128
TABLE 164 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2020–2025 (USD MILLION) 129
TABLE 165 UK: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 129
TABLE 166 UK: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 129
_
9.3.4 ITALY 129
9.3.4.1 Italy is witnessing an increase in the number of blood donors 129
9.3.4.2 COVID-19 Impact Analysis 130
TABLE 167 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 130
TABLE 168 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 130
TABLE 169 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 130
TABLE 170 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 131
TABLE 171 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 131
TABLE 172 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 131
TABLE 173 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 132
TABLE 174 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 132
TABLE 175 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 132
TABLE 176 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 133
TABLE 177 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 133
TABLE 178 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 133
TABLE 179 ITALY: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 133
TABLE 180 ITALY: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 134
9.3.5 SPAIN 134
9.3.5.1 Increasing adoption of NAT technology will support market growth 134
TABLE 181 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 134
TABLE 182 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 135
TABLE 183 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 135
TABLE 184 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 135
TABLE 185 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 135
TABLE 186 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 136
TABLE 187 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 136
TABLE 188 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 136
TABLE 189 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 137
TABLE 190 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 137
TABLE 191 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 137
TABLE 192 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 138
TABLE 193 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 138
TABLE 194 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 138
9.3.6 REST OF EUROPE 139
TABLE 195 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 139
TABLE 196 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 139
TABLE 197 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 139
TABLE 198 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 140
TABLE 199 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 140
TABLE 200 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 140
TABLE 201 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 140
TABLE 202 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 141
TABLE 203 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 141
TABLE 204 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 141
TABLE 205 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 142
TABLE 206 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 142
TABLE 207 ROE: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 142
TABLE 208 ROE: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 142
9.4 ASIA PACIFIC 143
FIGURE 13 ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT 143
TABLE 209 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019
(USD MILLION) 144
TABLE 210 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025
(USD MILLION) 144
TABLE 211 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 144
TABLE 212 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 145
TABLE 213 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 145
TABLE 214 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 145
TABLE 215 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 146